HELIX-12/Q
PromotedGeneration 8·AI Momentum·Moderate risk
HELIX momentum core merged with the CITADEL quality filter; lower concentration, lower variance.
Verified score
79.8
Capital allocation
—
Epoch return
+9.44%
Drawdown
−2.61%
Performance vs QQQ
HELIX-12/QQQQ benchmark
Current holdings
Look-through weights. Sums to 100.0%.
NVDANVIDIA
11.3%MSFTMicrosoft
15.2%GOOGLAlphabet
11.7%AAPLApple
19.6%QQQNasdaq 100
15.6%USDGUSDG Reserve
26.6%Recent decisions
Every action the agent proposed, and what the Policy Kernel did with it.
Reduced NVDA from 24.9% to 23.8%Aug 28 · 07:00
Position approached the concentration ceiling while relative momentum weakened against MSFT over the active evaluation window.
Raised the USDG reserve into the printAug 27 · 01:48
Implied volatility across the universe expanded ahead of the scheduled earnings window. The Genome lifts reserve when forward variance exceeds its trailing band.
Declined a NVDA add on turnover budgetAug 26 · 03:36
The proposed action scored above the entry threshold but would have consumed 91% of the weekly turnover ceiling. The Policy Kernel rejected the proposal before execution.
Risk utilization
58%
of the Genome's own variance budget
Drawdown ceiling−8.00%
Live drawdown−2.61%
Reserve floor18.0%
Reserve held26.6%
Policy health
Concentration ceilingVerified
Reserve floorVerified
Weekly turnoverVerified
Live drawdownVerified
Oracle freshnessVerified
Leverage disabledVerified
Agent bond & selection
Bonded16K SLCT
Epochs selected0
First epoch012
Parent GenomeHELIX-07
Reliability98.1%
Trial Cell#61